We are live on ! Find out more
HCC

Hirtle Callaghan & Co Portfolio holdings

AUM $2.92B
1-Year Est. Return 17.65%
This Fund
S&P 500
This Quarter Est. Return
+4.74%
1 Year Est. Return
+17.65%
3 Year Est. Return
+46.66%
5 Year Est. Return
+38.61%
10 Year Est. Return
+120.72%
AUM
$432M
AUM Growth
-$172M
Cap. Flow
-$187M
Cap. Flow %
-43.4%
Top 10 Hldgs %
49.68%
Holding
678
New
118
Increased
50
Reduced
76
Closed
104

Sector Composition

Rank Sector Weight
1 Consumer Staples 36.47%
2 Financials 11.08%
3 Energy 8.67%
4 Technology 8.38%
5 Healthcare 7.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
V icon
326
Visa
V
$677B
$22K 0.01%
328
EWY icon
327
iShares MSCI South Korea ETF
EWY
$21.7B
$21K ﹤0.01%
375
RRC icon
328
Range Resources
RRC
$9.11B
$21K ﹤0.01%
+400
New +$25.9K
STBA icon
329
S&T Bancorp
STBA
$1.86B
$21K ﹤0.01%
698
HRB icon
330
H&R Block
HRB
$5.18B
$20K ﹤0.01%
592
IXJ icon
331
iShares Global Healthcare ETF
IXJ
$4.11B
$20K ﹤0.01%
400
ASB icon
332
Associated Banc-Corp
ASB
$5.82B
$19K ﹤0.01%
1,002
PBT
333
Permian Basin Royalty Trust
PBT
$1.36B
$19K ﹤0.01%
2,000
PTEN icon
334
Patterson-UTI
PTEN
$3.87B
$19K ﹤0.01%
1,175
GRA
335
DELISTED
W.R. Grace & Co.
GRA
$19K ﹤0.01%
200
BRO icon
336
Brown & Brown
BRO
$22.9B
$18K ﹤0.01%
1,104
EXPD icon
337
Expeditors International
EXPD
$22.9B
$18K ﹤0.01%
400
NBR icon
338
Nabors Industries
NBR
$1.23B
$18K ﹤0.01%
28
+20
+250% +$15.8K
NBSE
339
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$18K ﹤0.01%
6
NWLIA
340
DELISTED
NATL WESTN LIFE INS CO CL A
NWLIA
$18K ﹤0.01%
67
SO icon
341
Southern Company
SO
$110B
$17K ﹤0.01%
340
TBBK icon
342
The Bancorp
TBBK
$2.79B
$17K ﹤0.01%
1,600
VYX icon
343
NCR Voyix
VYX
$1.06B
$17K ﹤0.01%
978
ESSX
344
DELISTED
ESSEX RENTAL CORP. COMMON STOCK
ESSX
$17K ﹤0.01%
12,623
EWZ icon
345
iShares MSCI Brazil ETF
EWZ
$9.05B
$16K ﹤0.01%
425
RGA icon
346
Reinsurance Group of America
RGA
$15.7B
$16K ﹤0.01%
180
TCRT icon
347
Alaunos Therapeutics
TCRT
$4.74M
$16K ﹤0.01%
22
TGNA
348
DELISTED
TEGNA Inc
TGNA
$16K ﹤0.01%
956
DNR
349
DELISTED
Denbury Resources, Inc.
DNR
$16K ﹤0.01%
+2,000
New +$20.7K
CHK
350
DELISTED
Chesapeake Energy Corporation
CHK
$16K ﹤0.01%
4

Similar funds

Hirtle Callaghan & Co's Q4 2014 Portfolio in Review

As of Q4 2014, Hirtle Callaghan & Co held 678 positions worth $432M, down 28% from $603M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Hirtle Callaghan & Co withdrew a net $187M in Q4 2014, closing 104 positions and reducing 76 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $98.3M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 36% of assets, up from 25% a quarter earlier, followed by Financials and Energy.

Against the trend, Hirtle Callaghan & Co opened a new position in JPMorgan Chase worth $2.04M.

  • Hirtle Callaghan & Co's largest Q4 2014 buy was JPMorgan Chase: 32,530 shares worth $2.04M.
  • Hirtle Callaghan & Co added most to Kinder Morgan in Q4 2014, an estimated $4.36M increase.
  • Hirtle Callaghan & Co's biggest Q4 2014 reduction was Stryker, cutting an estimated $973K.
  • Hirtle Callaghan & Co fully exited iShares MSCI Emerging Markets ETF in Q4 2014, selling an estimated $98.3M.
  • Hirtle Callaghan & Co's ten largest holdings make up 50% of its $432M portfolio in Q4 2014.
  • Hirtle Callaghan & Co opened 118 new positions and closed 104 in Q4 2014.
  • Hirtle Callaghan & Co's portfolio value fell 28% quarter-over-quarter to $432M.

Based on Hirtle Callaghan & Co's 13F filing for Q4 2014, filed 26 Jan 2015.